Organization · Other
GeneWorx Capital
GeneWorx Capital is a technology venture development firm based in Cambridge, MA, specializing in life science companies. They focus on accelerating commercialization and growth through strategic partnerships and capital raising.
Overview
What GeneWorx Capital does
What GeneWorx Capital is
GeneWorx Capital is a technology venture development firm based in Cambridge, MA, specializing in life science companies. They focus on accelerating commercialization and growth through strategic partnerships and capital raising.
How it participates in the startup ecosystem
The current public profile supports funder and community capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Other
- Founded
- Founded in 2017
- Approximate age
- About 9 years
- Structured capabilities
- Funder · Community
- Last reviewed
- April 26, 2026
Official channels
Find GeneWorx Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
GeneWorx Capital as a funder
Investment thesis
GeneWorx Capital aims to build high-value enterprises from life-science innovations by combining capital access, corporate-development relationships, strategic positioning, M&A experience, and company-building support.
Focus narrative
GeneWorx Capital provides strategic, technology, and financial advisory services to early-stage life science companies. Their services include capital raising from a network of over 1,000 investment funds, structuring partnerships with larger companies for market validation and revenue generation, and assisting university tech transfer offices in enhancing the commercialization of university intellectual property.
Value beyond capital
GeneWorx Capital adds value by leveraging its extensive network to facilitate capital raising, structuring strategic partnerships, and enhancing visibility with analysts and investment bankers. The firm focuses on projects with high revenue potential and strong alignment with large company roadmaps.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series B · Growth Equity
- Sectors
- Biotech · Healthcare · Diagnostics · Medical Devices · Synthetic Biology · Drug Discovery · Industrial
- Regions
- North America · Global
Availability
- Currently deploying
- Not published
Portfolio and track record
Portfolio context
GeneWorx Capital has worked with a variety of life science innovations, including a rapid point-of-care diagnostic test platform, a peptide drug conjugate platform for difficult cancers, and a universal coronavirus vaccine. However, specific portfolio companies are not publicly disclosed.
Capability profile
GeneWorx Capital as a community
Community overview
GeneWorx Capital is a technology venture development firm based in Cambridge, MA, founded by a team of MIT technologists, former Wall Street venture capital investors, and Silicon Valley tech entrepreneurs. The organization focuses on building high-value enterprises from emergent life science companies and innovations, aiming to accelerate commercialization and growth for startups, spinouts from labs, and businesses within larger companies.
Community focus
GeneWorx Capital provides strategic, technology, and financial advisory services to early-stage life science companies. Their services include capital raising from a network of over 1,000 investment funds, structuring partnerships with larger companies for market validation and revenue generation, and assisting university tech transfer offices in enhancing the commercialization of university intellectual property.
Member value
Members benefit from access to a vast network of investment funds, strategic partnerships with larger corporations, and expert advisory services tailored to the life sciences sector. GeneWorx Capital helps startups navigate the complexities of commercialization and growth, ensuring they are well-positioned for success in the competitive life science landscape.
Membership
- Pricing models
- fixed-tuition
Format and cadence
- Modality
- in-person
- Schedule
- rolling-admissions
- Commitment
- light
Audience and fit
- Audience
- Founders · Investors · Corporate Innovators
- Benefits
- network-access and mentorship
- Program types
- community and other
- Selection criteria
- application
- Stages
- Pre-seed · Seed
- Regions
- North America
Community activity
Notable members
Founding partners include George Lauro, a technology entrepreneur and venture capitalist, and William Kazman, an MIT engineer with extensive experience in life sciences and technology.
Common questions
What to know about GeneWorx Capital
Upseed classifies GeneWorx Capital under the Other organization type. Its current public profile includes funder and community capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 26, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.